XML 85 R5.htm IDEA: XBRL DOCUMENT v3.20.1
UNAUDITED CONDENSED STATEMENTS OF CONSOLIDATED CASH FLOWS - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Cash flows from operating activities:    
Net loss $ (367,199) $ (31,477)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:    
Depreciation, depletion and amortization 15,556 11,166
Impairment expense 455,031 0
(Gain) loss on derivative instruments (104,096) 32,393
Cash settlements (paid) received on expired derivative instruments 12,522 (1,277)
Bad debt expense 110 101
Amortization and write-off of deferred financing costs 309 308
Accretion of asset retirement obligations 1,513 1,311
Share-based compensation (see Note 11) (1,112) 1,443
Settlement of asset retirement obligations 0 (162)
Changes in operating assets and liabilities:    
Accounts receivable 8,381 4,326
Prepaid expenses and other assets (349) (6,856)
Payables and accrued liabilities (7,399) (537)
Other (178) 61
Net cash provided by operating activities 13,089 10,800
Cash flows from investing activities:    
Additions to oil and gas properties (12,416) (10,370)
Additions to other property and equipment (304) (62)
Additions to restricted investments 0 (68)
Net cash used in investing activities (12,720) (10,500)
Cash flows from financing activities:    
Advances on revolving credit facilities 25,000 0
Payments on revolving credit facilities (20,000) (24,000)
Deferred financing costs 0 (101)
Dividends to stockholders (3,786) 0
Common stock repurchased and retired under the share repurchase program 0 (920)
Costs incurred in conjunction with tender offer 0 (107)
Restricted units returned to plan (14) 0
Net cash provided by (used in) financing activities 1,200 (25,128)
Net change in cash, cash equivalents and restricted cash 1,569 (24,828)
Cash, cash equivalents and restricted cash, beginning of period 325 50,029
Cash, cash equivalents and restricted cash, end of period $ 1,894 $ 25,201